Evidence map›Paper›PMID 36418241›Full record

ArticleJournal of medical virology2023

Viral reactivation in the lungs of patients with severe pneumonia is associated with increased mortality, a multicenter, retrospective study.

Lingtong Huang, Xuan Zhang, Lisha Pang, Peng Sheng, Yanqiu Wang, Fan Yang, Huili Yu, Xiaohan Huang, Yue Zhu, Ning Zhang and 3 more

Open access · hybridAbstract readMulticenter Study
In one paragraph

Article in Journal of medical virology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 1 pooled it
9.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 1 synthesis or guideline pooled it, 65 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Torque teno virus in the lower respiratory tract: association with immunosuppression but not mortality in severe pneumonia-a multicenter retrospective cohort study.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Article
  13. iScience · 2025
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Observational
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 1 country.

Lingtong HuangDepartment of Critical Care Units, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Xuan ZhangDepartment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Lisha PangDepartment of Critical Care Units, Tongde Hospital of Zhejiang Province, Hangzhou, China.
Peng ShengDepartment of Critical Care Units, The First Hospital of Jiaxing, Jiaxing, China.
Yanqiu WangDepartment of Critical Care Units, Hangzhou Hospital of Traditional Chinese Medicine, Hangzhou, China.
Fan YangDepartment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Huili YuDepartment of Critical Care Units, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Xiaohan HuangDepartment of Nephrology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Yue ZhuDepartment of Critical Care Units, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Ning ZhangDepartment of Emergency Medicine, Lishui City People's Hospital, Lishui, China.
Hongliu CaiDepartment of Critical Care Units, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Lingling TangDepartment of Infectious Diseases, Shulan (Hangzhou) Hospital, Zhejiang Shuren University of Shulan International Medical College, Hangzhou, China.
Xueling FangDepartment of Critical Care Units, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
First Affiliated Hospital Zhejiang University · CNFirst Hospital of Jiaxing · CNHangzhou Hospital of Traditional Chinese Medicine · CNLishui City People's Hospital · CNTongde Hospital of Zhejiang Province · CNZhejiang Shuren University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Viral reactivation is widespread in patients with severe pneumonia, yet the landscape of viral reactivation in the lungs is not well-known. This study aims to assess the landscape and clinical features of viral reactivation in the early onset of severe pneumonia in ICU patients. The clinical data from 97 patients were collected retrospectively from the intensive care units of five teaching hospitals between June 2018 and July 2021. Metagenomic next-generation sequencing (mNGS) of the bronchoalveolar lavage fluid (BALF) was performed at the onset of severe pneumonia. Cytomegalovirus (CMV), herpes simplex virus-1 (HSV-1), and Epstein-Barr virus (EBV) were the most common reactivated viruses in the lower respiratory tract of patients with severe pneumonia. After adjusting for the risk of confounding and competition of age, sex, sequential organ failure assessment, acute physiology chronic health assessment II and immunosuppression status, viral reactivation resulted in an overall 2.052-fold increase in 28-day all-cause mortality (95% CI: 1.004-4.194). This study showed that CMV, HSV-1, and EBV were the most common reactivated viruses in the lungs of patients with severe pneumonia. The existence of viral reactivations was associated with an increased risk of mortality. The simultaneous reactivation of multiple viruses needs to be considered in the design of clinical trials.

Indexed as

Cytomegalovirus InfectionsEpstein-Barr Virus InfectionsHerpesvirus 1, HumanPneumoniaPneumonia, ViralCytomegalovirusHerpesvirus 4, HumanHumansLungRetrospective StudiescytomegalovirusEpstein-Barr virusherpes simplex virusmNGSreactivation

Identifiers

PMID36418241
PMCPMC10099828
OpenAlexW4309859137

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.